Medeologix, a Taiwan-based medtech CDMO company, has announced its successful acquisition of three premier medical device manufacturing companies to form an integrated full function service group. The newly formed Medeologix family of companies, with a combined footprint of 90,000 sq.ft, offers one-stop services from conceptual design to high-volume production.

The three Silicon Valley companies, Mediballoon, MedeonBio and Second Source Medical, along with Medeologix with a mass production facility in Taiwan, form the vertically integrated services from medical tubing extrusion, balloon forming, catheter processing, final assembly to packaging and logistic services.

MediBalloon, established in 2016, is an expert in extruding medical tubing and developing medical balloons in different shapes and sizes using various thermoplastic materials including Polyurethane, Polyethylene, Polyvinylidene fluoride (PVDF), Polybutylene terephthalate (PBT), Polyethylene terephthalate (PET), PEBAX, and Nylons. 

On the other hand, MedeonBio, established in 2012, specializes in single and multi-lumen catheter processes, including braiding, coil winding, lamination, thermal fusing, tipping, balloon bonding and pleating, as well as hydrophilic coating. These catheters are commonly used in minimally invasive procedures for cardiovascular, neurovascular, peripheral and structural heart diseases.

While Second Source Medical, established in 2004, is an FDA registered contract manufacturer providing rapid response of integrated design and manufacturing services from component, functional prototype, subassembly, process development, verification and validation leading to pilot and mass productions in support of successful clinical trial, regulatory approval and commercialisation.